Comparison · NCT02067039-24f18af0
HIV Self-testing vs Information Only: Newly Identified HIV Infections
Calculated by ConductScience from the counts the trial posted to ClinicalTrials.gov.
2 sourcestrial-comparisons-2026-03-23-0.1.0
Cite this record
ConductScience Library. HIV Self-testing vs Information Only: Newly Identified HIV Infections. Trial comparisons, record NCT02067039-24f18af0. Release trial-comparisons-2026-03-23-0.1.0, 23 Mar 2026. https://conductscience.org/library/comparisons/NCT02067039-24f18af0
On this page
Measures6
Calculated by ConductScience from the counts the trial posted to ClinicalTrials.gov.
| Measure | Value | 95% interval, lower | 95% interval, upper | Method | Note |
|---|---|---|---|---|---|
| Risk in group 1 | 0.0189 | 0.0128 | 0.0277 | wilson | |
| Risk in group 2 | 0.00821 | 0.00459 | 0.0146 | wilson | |
| Risk difference, group 1 minus group 2 | 0.0107 | 0.00183 | 0.0202 | newcombe hybrid score | |
| Risk ratio, group 1 over group 2 | 2.3 | 1.14 | 4.65 | log | |
| Odds ratio, group 1 over group 2 | 2.32 | 1.14 | 4.74 | log | |
| Number needed to treat, for one more participant with the outcome on HIV Self-testing than on Information Only | 93.8 | 49.5 | 548 | from the risk difference interval |
Source ClinicalTrials.gov
Groups2
Neither group, or both, names a comparator, so the groups keep ClinicalTrials.gov's order.
| Group | Title | Description | With the outcome | Analysed | ClinicalTrials.gov code |
|---|---|---|---|---|---|
| Group 1 | HIV Self-testing | The intervention group of MSM (HIV negative or unaware of HIV status) will receive 4 rapid HIV test kits - 2 oral fluid tests (OraQuick), and 2 finger-stick blood tests (Sure Check). Men in the randomized controlled trial will complete short follow-up surveys at 3-month intervals during the 12-month follow-up period, and men in the intervention arm will be allowed to order additional test kits to replenish the ones they use or give away. At month 12, all HIV-negative or those who are unaware of their HIV status participants will be sent 1 oral fluid test (OraQuick), 1 finger-stick blood test (Sure Check), and a dried blood spot (DBS) specimen collection kit to be mailed to Emory University after collecting a blood sample for laboratory testing.~OraQuick in home \& Sure Check HIV tests: Provision of OraQuick in home \& Sure Check HIV tests | 25 | 1,325 | OG000 |
| Group 2 | Information Only | All comparison group of MSM (HIV negative or unaware of HIV status) will take a baseline survey. Men in the randomized controlled trial will complete short follow-up surveys at 3-month intervals during the 12-month follow-up period. At month 12, all HIV-negative and unaware of their HIV status comparison arm participants will be sent 1 oral fluid test (OraQuick), 1 finger-stick blood test (Sure Check), and a DBS specimen collection kit to be mailed to Emory University after collecting a blood sample for laboratory testing. | 11 | 1,340 | OG001 |
Source ClinicalTrials.gov
Outcome
- Type
- SECONDARY
- Title
- Newly Identified HIV Infections
- Description
- Report of positive HIV test result (self-test or provider testing)
- Time frame
- 12 months
- Population
- All persons assigned to study.
Source ClinicalTrials.gov
Trial
- Title
- Evaluation of Rapid HIV Self-testing Among MSM (eSTAMP)
- NCT number
- NCT02067039
- Phases
- NA
- Conditions
- HIV Infection
- Interventions
- OraQuick in home & Sure Check HIV tests
- Lead sponsor
- Centers for Disease Control and Prevention
- Results first posted
- 2020-03-31
- Results on ClinicalTrials.gov
- https://clinicaltrials.gov/study/NCT02067039?tab=results
Source ClinicalTrials.gov
Source
- Release
- trial-comparisons-2026-03-23-0.1.0
- Release manifest SHA-256
- f66225897fbf258b57ea10bdacfd0347d3cdfda93f7f5685234b7e06ea36fa57
- AACT copy
- 2026-03-23
- Tables read
- outcome_counts.parquet, outcome_measurements.parquet, outcomes.parquet, reported_event_totals.parquet, reported_events.parquet, result_groups.parquet, studies.parquet, ctgov_trial.parquet
Source ClinicalTrials.gov
Sources 2
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions. The measures are ConductScience's calculation from them.
For software
Read this comparison from software.
The record is JSON. No key.
GET https://conductscience.org/api/comparisons/v1/NCT02067039-24f18af0